DOSAGE AND ADMINISTRATION
FORTEO should be administered as a subcutaneous injection into the thigh or abdominal wall. The recommended dosage is 20 mcg once a day.
FORTEO should be administered initially under circumstances in which the patient can sit or lie down if symptoms of orthostatic hypotension occur (see PRECAUTIONS, Information for the Patient).
FORTEO is a clear and colorless liquid. Do not use if solid particles appear or if the solution is cloudy or colored. The FORTEO pen should not be used past the stated expiration date.
No data are available on the safety or efficacy of intravenous or intramuscular injection of FORTEO.
The safety and efficacy of FORTEO have not been evaluated beyond 2 years of treatment. Consequently, use of the drug for more than 2 years is not recommended.
INSTRUCTIONS FOR PEN USE
Patients and caregivers who administer FORTEO should receive appropriate training and instruction on the proper use of the FORTEO pen from a qualified health professional. It is important to read, understand, and follow the instructions in the FORTEO pen User Manual for priming the pen and dosing. Failure to do so may result in inaccurate dosing. Each FORTEO pen can be used for up to 28 days including the first injection from the pen. After the 28–day use period, discard the FORTEO pen, even if it still contains some unused solution. Never share a FORTEO pen.
The FORTEO pen should be stored under refrigeration at 2° to 8°C (36° to 46°F) at all times. Recap the pen when not in use to protect the cartridge from physical damage and light. During the use period, time out of the refrigerator should be minimized; the dose may be delivered immediately following removal from the refrigerator.
Do not freeze. Do not use FORTEO if it has been frozen.